DexCom gets FDA OK to calibrate Seven, its continuous glucose monitoring system

YES!!!!!!!   YEAH!  This will make life easier.  I had to come back home on Monday because I forgot my cable and had just started a new sensor.

DexCom Inc. (NASDAQ:DXCM) Friday said it received approval from the Food and Drug Administration to calibrate Seven, its seven-day continuous glucose monitoring system, using any FDA-cleared blood glucose meter.

DexCom gets FDA OK to calibrate Seven, its continuous glucose monitoring system

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *